Multivoxel magnetic resonance spectroscopy in a rhizomelic chondrodysplasia punctata case

Journal of Child Neurology

Volumn 20, Issue 8, 2005, Pages 698-701

  Siǧirci, Ahmet ^a   Alkan, Alpay ^a   Kutlu, Ramazan ^a   Gülcan, Hande ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CATARACT; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FACE DYSMORPHIA; FEEDING DISORDER; FLEXION CONTRACTURE; HUMAN; HYPERTELORISM; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIGHT HEMISPHERE; THROMBOCYTOPENIA; VITREOUS HEMORRHAGE;

BRAIN; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 30944446813     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200081401     Document Type: Article

References (14)

1. Brookhyser KM, Lipson MH, Moser AB, et al: Prenatal diagnosis of rhizomelic chondrodysplasia, punctata due to isolated alkyldihydroacetonephosphate acyltransferase synthase deficiency. Prenat Diagn 1999;19:383-385.
2. Powers JM, Moser HW: Peroxisomal disorders: Genotype, phenotype, major neuropathologic lesions and pathogenesis. Brain Pathol 1998;8:101-120.
3. Ofman R, Hettema EH, Hogenhout EM, et al: Acyl-CoA: Dihydroxyacetonephosphate acyltransferase: Cloning of the human cDNA, and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum Mol Genet 1998;7:847-853.
4. Williams DW, Elster AD, Cox TD: Cranial MR imaging in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 1991;12:363-365.
5. Sztriha L, Al-Gazali LI, Wanders RJ, et al: Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency). Dev Med Child Neurol 2000;42:492-495.
6. Van der Knaap MS, Valk J: The MR spectrum of peroxisomal disorder. Neuroradiology 1991;33:30-37.
7. Alkan A, Kutlu R, Yakinci C, et al: Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. Magn Reson Imaging 2003;21:77-80.
8. Viola A, Confort-Gouny S, Ranjeva JP, et al: MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 2002;23:480-483.
9. Braverman N, Steel G, Obie C, et al: Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 1997;15:369-376.
10. Wanders RJ: Peroxisomal disorders: Clinical, biochemical and molecular aspects. Neurochem Res 1999;24:565-580.
11. Cecil KM, Jones BV: Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12:435-452.
12. Castillo M, Kwock L, Mukherji SK: Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15.
13. Barkovich AJ: Normal development of the neonatal and infant brain, skull, and spine, in Barkovich AJ (ed): Pediatric Neuroimaging, 3rd ed. Philadelphia, Lippincott Williams & Wilkins, 2000, 13-70.
14. Wardinsky TD, Pagon RA, Powell BR, et al: Rhizomelic chondrodysplasia punctata and survival beyond one year. A review of the literature and five case reports. Clin Genet 1990;38:84-93.